Belfast, UK and Short Hills, NJ – August 14, 2025 – Diaceutics, the leading technology and solutions provider leveraging AI-driven diagnostic and genomic data to drive therapy adoption, today announced its integration into Marketplace, powered by Doceree, the world’s first global network of physician only programmatic platforms. This collaboration creates a new industry standard for HCP audience targeting, enabling life sciences marketers to reach treaters with unmatched clinical precision, at the exact moments that matter most.
With this partnership, Diaceutics’ multimodal audience segments built from real-world diagnostic, lab, and genomic profile data are now directly accessible to media buyers within the Doceree ecosystem. These audiences give pharmaceutical marketers the ability to go beyond traditional claims-based targeting by engaging physicians based on real-time diagnostic behaviors, biomarker testing, and disease progression insights. For media buyers, it means faster activation, deeper visibility into true treaters, and more relevant messaging at the point of treatment decision.
Doceree empowers life sciences brands to connect with physicians across over 150 EHR, eRx, and telehealth platforms, delivering targeted messaging in endemic and clinical environments where HCPs make decisions. Now, over 100 pre-built Diaceutics audience segments covering general conditions like diabetes, CKD, or cardiovascular disease, to biomarker driven precision therapies in oncology, as well as select rare diseases , marketers can:
- Target HCPs based on a patient’s clinical journey and influence behavior at the point of treatment decision
- Close the recency gap inherent in claims data using real-time diagnostic and lab-based triggers
- Uncover and message those treating HCPs missed in absent claims but captured in the patient journey
“For marketers trying to influence physician behavior in real-time, data depth and context are everything,” said Scott Phillips, VP, Real World Data at Diaceutics. “This partnership unlocks a new level of campaign intelligence empowering brand and omnichannel teams to engage treaters earlier, faster, and more meaningfully based on what’s actually happening with patients in the moment, not just what happened months ago.”
“At Doceree, we’re reimagining how and where healthcare brands communicate with physicians ,” said Julius Ramirez, SVP Partnerships at Doceree. “Partnering with Diaceutics enhances our ability to deliver truly relevant, timely engagement by aligning campaign execution to the real-world diagnostic journey. It’s a step forward in our mission to make HCP engagement smarter and more impactful across every moment of care.”
About Diaceutics
At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. For 20 years, Diaceutics has specialized in delivering precision medicine and diagnostic solutions to the world’s top pharma and biotechs. By bridging the gap between biomarker testing and targeted therapies, Diaceutics empowers industry partners to succeed in the evolving field of personalized healthcare
About Doceree
Leading the way in making HCP-patient conversations richer and more meaningful through patented responsive technology, Doceree addresses both current and emerging challenges for healthcare and life sciences organizations in HCP-patient engagement, particularly where digital and technological advancements play a crucial role. We leverage our patented technology to ensure that HCP-patient conversations and interactions are more meaningful, richer, and outcome-oriented.
